Essen BioScience, Inc.

300 West Morgan Road,
Ann Arbor, Michigan 48108
United States,
(734) 769-1600
www.essenbioscience.com

Essen BioScience, Inc. is a provider of field of cell-based assays and instrumentation used for drug discovery and basic research applications.

Essen BioScience was acquired by Sartorius Stedim Biotech S.A. on March 03, 2017.

Join Mergr to view all 127 acquisitions of medical products companies in 2017, including 14 acquisitions by private equity firms, and 113 by strategics.

Out of 60 sectors in the Mergr database, medical products ranked 12 in number of deals in 2017. The largest medical products acquisition in 2017 was Medtronic - Patient Care Deep Vein Thrombosis & Nutritional Insufficiency Businesses - which was acquired by Cardinal Health for $6.1B.

Join Mergr to view this profile - and discover more medical products acquisitions of companies like Essen BioScience.


What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.1K Private Equity Firms
  • 110K M&A Transactions
  • 120K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 38K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.